An open label, randomized phase 3 clincal trial of Nivolumab vs therapy of investigator's choice in recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck (SCCHN)

Administered By

Awarded By

Contributors

Start/End

  • March 1, 2014 - August 30, 2021